Standard Operating Procedure for Global Regulatory Assessment of Manufacturing Changes
| Department | Regulatory Affairs |
| SOP No. | RA/2026/676 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 11/04/2026 |
| Effective Date | 11/04/2026 |
| Review Date | 11/04/2028 |
Purpose
This SOP defines the standardized process for assessing manufacturing changes at a global level to ensure timely regulatory compliance and seamless post-approval management. It supports control objectives by establishing a compliant, systematic approach for evaluating, documenting, and submitting variations related to manufacturing changes, minimizing risks to product quality, safety, and regulatory status.
Scope
This SOP applies to all manufacturing changes across all functional areas, dosage forms, and production sites under the company’s global regulatory jurisdiction. It encompasses changes affecting processes, equipment, facilities, validation status, and materials that require regulatory assessment and submission. The SOP excludes non-manufacturing related changes, such as marketing or commercial updates, unless they directly impact manufacturing control or regulatory filings.
Responsibilities
The following roles are involved in executing and overseeing the regulatory assessment of manufacturing changes:
- Change Initiators/Functional Users: Identify, document, and submit change requests with necessary technical data.
- Regulatory Affairs Team: Perform regulatory classification, impact assessment, and prepare required variation dossiers.
- Quality Assurance: Review and approve change documentation, ensuring compliance with GMP and regulatory requirements.
- Manufacturing/Operations: Provide technical input, impact validation, and implement approved changes.
- Validation/Engineering: Assess and update validation status impacted by changes.
- Document Control: Manage change-related documents, approvals, and record retention.
Accountability
The Regulatory Affairs Head is accountable for ensuring this SOP is implemented effectively, remains compliant with current regulations, and is periodically reviewed for relevance and effectiveness. They are also responsible for escalation of regulatory risks, coordination with global affiliates, and ensuring training and record-keeping related to the SOP.
Procedure
1. Identification and Initiation: Any proposed manufacturing change must be formally documented on the Change Request Form by the initiator, detailing the nature, rationale, scope, and expected impact of the change.
2. Preliminary Assessment: The Regulatory Affairs team reviews the information, confirming the change’s applicability to regulated manufacturing aspects and determining preliminary regulatory impact.
3. Classification: Based on regional and global regulatory guidelines (e.g., ICH, EMA, FDA), Regulatory Affairs classifies the change as: minor, moderate, or major, guiding submission timelines and documentation requirements.
4. Cross-Functional Review: Regulatory Affairs coordinates with Quality Assurance, Manufacturing, Validation, and Engineering to evaluate impacts on GMP compliance, product quality, process validation, and facility qualifications.
5. Documentation Preparation: Required technical dossiers, amendment forms, and supporting data such as validation summaries, risk assessments, and stability data (if applicable) are compiled into the regulatory submission package.
6. Approval and Authorization: The complete package undergoes thorough review and approval by Quality Assurance and the Regulatory Affairs Head prior to submission.
7. Regulatory Submission and Tracking: Regulatory Affairs submits the variation dossier to relevant health authorities according to local requirements and maintains a tracking log to monitor submission status, communication, and approvals.
8. Implementation Readiness: Upon receipt of approval or confirmation that no prior approval is required, change activities proceed per validated procedures. Manufacturing ensures availability of updated instructions and training is conducted if needed.
9. In-Process and Post-Change Controls: Implement in-process monitoring and verification to confirm that the change was executed as approved and product quality remains within defined parameters.
10. Deviation Handling: Any unexpected outcomes or deviations during or after change implementation must be documented, investigated, and addressed per the deviation management SOP.
11. Documentation and Record Retention: All change control records, approvals, regulatory correspondence, and supporting data shall be maintained securely in accordance with document retention policies and made available for audits.
12. Periodic Review: Periodic effectiveness audits shall be conducted by Regulatory Affairs to assess compliance with this SOP and identify improvement opportunities.
Abbreviations
GMP – Good Manufacturing Practice
SOP – Standard Operating Procedure
QA – Quality Assurance
RA – Regulatory Affairs
ICH – International Council for Harmonisation
EMA – European Medicines Agency
FDA – Food and Drug Administration
Documents
- Change Request Form for Manufacturing Changes (Annexure-1)
- Regulatory Impact Assessment Checklist (Annexure-2)
- Regulatory Submission Tracking Log (Annexure-3)
References
1. ICH Q12 – Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management
2. EMA Guideline on the Investigation of Change and Variations
3. FDA Guidance for Industry – Changes to an Approved Application
4. Company Quality Manual and Change Control Procedures
5. Regional regulatory agency requirements for variations and post-approval changes
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Change Request Form for Manufacturing Changes
Purpose: To formally document detailed information on the proposed manufacturing change, including rationale, scope, and initial assessments for regulatory review.
| Change Request No. | CR-2026-045 |
| Department | Manufacturing |
| Date of Request | 01/03/2026 |
| Description of Change | Replacement of manufacturing equipment for batch 101 processing line |
| Reason for Change | Equipment obsolescence and need for improved efficiency |
| Impact on Product/Process | Potential alteration of process parameters and validation requirements |
| Attachments Included | Equipment specifications, validation summary |
| Initiator Signature | __________________ |
| Approval Signature | __________________ |
Annexure-2: Regulatory Impact Assessment Checklist
Purpose: To systematically evaluate the regulatory implications of the proposed manufacturing change to ensure appropriate classification and submission strategy.
| Change Request No. | CR-2026-045 |
| Change Classification | Major |
| Applicable Regulatory Guidelines | ICH Q12, EMA Variation Guideline |
| Potential Impact Areas | Process Validation, Product Stability, Regulatory Submission |
| Supporting Documents Required | Validation protocols, Risk assessment report, Updated batch records |
| Assessment Completed By | __________________ |
| Date | 05/03/2026 |
Annexure-3: Regulatory Submission Tracking Log
Purpose: To maintain records of all regulatory submissions related to manufacturing changes, tracking submission dates, correspondence, and approval status.
| Submission ID | Change Request No. | Regulatory Authority | Submission Date | Status | Approval Date | Comments |
|---|---|---|---|---|---|---|
| SUB-2026-008 | CR-2026-045 | EMA | 10/04/2026 | Approved | 15/05/2026 | Approved without queries |
| SUB-2026-009 | CR-2026-045 | FDA | 12/04/2026 | Pending | Under review |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 11/04/2026 | 1.0 | Initial issue | New SOP creation |